The Science Advisory Board is the source for discovery and development in the life sciences.
Washington, DC
Joined April 2009
- Tweets10.1K
- Following1.1K
- Followers6.6K
- Likes984
The Science Advisory Board retweeted
Market Research & New Product Development for Diagnostic and Scientific Markets
Register Now buff.ly/3LMtvjA
The Science Advisory Board retweeted
#ICYMI During last month's Meeting on the Med, Yan Zhang and Nori Ueno sat down with @ScienceBoard to discuss how Mission Bio is helping to better characterize cell and gene therapies and their takeaways from this year's meeting. Catch the interview here: bit.ly/3MJA87D
The Science Advisory Board retweeted
Our CSO, Tom McCauley, Ph.D., sat down with @ScienceBoard at #ASGCT22 to discuss our pioneering journey toward #PrecisionGenomicControl, our promising pipeline of #EpigenomicControllers, and upcoming company milestones. Watch the conversation here: bit.ly/39CgID5
The Science Advisory Board retweeted
Thank you to @ScienceBoard for a brilliant interview with David Smith, VP of Technical Operations.
David sat down to discuss the challenges of CGT manufacturing and how, at Ori, we're automating and standardizing CGT manufacturing.
Watch here ➡️scienceboard.net/index.aspx?…
The Science Advisory Board retweeted
Our CEO Ms Vered Caplan sat down with @ScienceBoard at the @ISCTglobal Annual Meeting 2022, to discuss how we can #simplify and #lowercosts of providing #CGT. Vered enjoyed talking to @waltschoenborn, in this interview, which you can see here: lnkd.in/eitdws3t
The Science Advisory Board retweeted
#Allogeneic vs. #autologous #celltherapy? #Celltherapies generated using a patient's own cells have their own inherent risks/limitations, Roman Vincent, MaxCyte's sr. global director of strategic marketing told ScienceBoard.net at #ISCT22 bit.ly/39qegzF #ISCT2022
The Science Advisory Board retweeted
A #cellandgenetherapy ecosystem is only way to accelerate #CGT development for more patients, Autolomous COO Kwok Pang told ScienceBoard.net at #ISCT22, with the company's digital platform as the 'glue' holding together disparate systems/equipment. bit.ly/3Ne36wv
The Science Advisory Board retweeted
#Automation, standardization have potential to overcome #cellandgenetherapy #manufacturing challenges, says David Smith, VP at Ori Biotech. Smith spoke to ScienceBoard.net at #ISCT22 about company's plans to use $100M in funding to launch platform. bit.ly/3NeBjfp
The Science Advisory Board retweeted
#ISCT22 Co-Chair Bambi Grilley, director of clinical research & early product development at Baylor College of Medicine, recounts how far #cellandgenetherapy field has come as #CGT #clinicaltranslation benefits patients. bit.ly/3kZr7vd #ISCT2022 #celltherapy #genetherapy
The Science Advisory Board retweeted
Quantori increases drug development efficiency with HPC Accelerator via @ScienceBoard #HPC #HighPerformanceComputing #drugdiscovery #biopharma #genomics #informatics
scienceboard.net/index.aspx?…
The Science Advisory Board retweeted
I had the opportunity to talk with @ScienceBoard at #ISCT2022 about #celltherapy #scaleup #manufacturing #innovation @irvinesci. Here is a link to the interview linkedin.com/feed/update/urn…
The Science Advisory Board retweeted
Orgenesis CEO Vered Caplan at #ISCT22 told @ScienceBoard several factors make #cellandgenetherapy complex, expensive, and difficult to bring to market. The #biotech company is addressing these CGT challenges by simplifying, lowering costs. bit.ly/3Fro605 #ISCT2022 #ISCT
The Science Advisory Board retweeted
Children's National sees improvements in the potency of existing #celltherapies, reduction in time it takes to get them to patients, Patrick Hanley, chief/director of the medical center's #CellularTherapy Program, told @ScienceBoard at #ISCT22 bit.ly/391hk4W #ISCT2022
The Science Advisory Board retweeted
Antion Biosciences CEO Sven Kili tells @ScienceBoard at #ISCT22 the company's #microRNA tech is new way of approaching #allogeneiccell creation, enables simultaneous silencing of multiple #genetargets and overcomes challenges with #geneediting bit.ly/38ba1rs #ISCT2022
The Science Advisory Board retweeted
Thanks @ScienceBoard for the opportunity to speak about our program at @ChildrensNatl and also speak to what we're doing at @ISCTglobal to develop the cell and gene therapy workforce. #ISCT2022
scienceboard.net/index.aspx?…
The Science Advisory Board retweeted
How an #ISCT working group is addressing #expandedaccess to better enable patients who are seriously or terminally ill access #investigationaltreatments, such as #cellandgenetherapy, outside of #clinicaltrials bit.ly/392oXbr #ISCT22 #ISCT2022 #celltherapy #genetherapy
The Science Advisory Board retweeted
#ISCT22: #Celltherapy has potential to address unmet medical needs in #orthopedics, says Miguel Forte, CEO of Bone Therapeutics, and president-elect of #ISCT bit.ly/3FoyfKQ #ISCT2022 #celltherapies #orthopaedics #celltherapies #tibialfractures #regenerativemedicine
The Science Advisory Board retweeted
@Scienceboard recently spoke with the University of Tübingen’s Dr. Juliane Walz, professor of peptide-based #immunotherapies, and research associate Claudia Tandler about the promising results their CoVac-1 #vaccine has shown in #immunocompromised patients bit.ly/38KzjfW
The Science Advisory Board retweeted
New DNA reference map may aid in identifying SMN1 mutations #NBTintheNews via @SMANewsToday smanewstoday.com/news-posts/…
The Science Advisory Board retweeted
#ICYMI: learn more about Context's lead candidate ONA-XR and preclinical CLDN6xCD3 bispecific antibody program #data presented at #AACR22 in this @ScienceBoard interview with CEO @MLehrPHL. $CNTX scienceboard.net/index.aspx?…